MYCN and neuroblastoma: A connection between ALK and MYC has been observed in neuroblastoma, where ALK gain-of-function mutations are more frequent in MYCN amplified tumors and activation of full length ALK increases mRNA, protein expression, and transformation potential of MYCN in neuroblastoma cell lines [21, 22].